Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S156000
Reexamination Certificate
active
07902227
ABSTRACT:
The present invention relates to C-7 isoxazolyl quinoline
aphthyridine derivatives useful as antimicrobial compounds, pharmaceutical compositions comprising said derivatives and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
REFERENCES:
patent: 4777253 (1988-10-01), Mitscher et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4894458 (1990-01-01), Masuzawa et al.
patent: 4990517 (1991-02-01), Petersen et al.
patent: 5017581 (1991-05-01), Nishitani et al.
patent: 5077429 (1991-12-01), Grohe et al.
patent: 5256662 (1993-10-01), Domagala et al.
patent: 5677456 (1997-10-01), Kim et al.
patent: 5688791 (1997-11-01), Kimura et al.
patent: 5822801 (1998-10-01), Varney
patent: 5869670 (1999-02-01), Hong et al.
patent: 5880283 (1999-03-01), Matsumoto et al.
patent: 6025370 (2000-02-01), Todu et al.
patent: 6156903 (2000-12-01), Yazaki et al.
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 6573260 (2003-06-01), Takemura et al.
patent: 7189847 (2007-03-01), Sato et al.
patent: 2002/0049192 (2002-04-01), Ledoussal
patent: 2002/0049223 (2002-04-01), Elmore et al.
patent: 3142854 (1981-10-01), None
patent: 023095 (1981-01-01), None
patent: 047005 (1982-03-01), None
patent: 195316 (1986-09-01), None
patent: 230053 (1986-12-01), None
patent: 304087 (1989-02-01), None
patent: 191451 (1989-08-01), None
patent: 342849 (1989-11-01), None
patent: 343524 (1989-11-01), None
patent: 153163 (1989-12-01), None
patent: 362759 (1990-11-01), None
patent: 153828 (1990-12-01), None
patent: 413455 (1991-02-01), None
patent: 421668 (1991-10-01), None
patent: 487030 (1992-05-01), None
patent: 572259 (1993-12-01), None
patent: 677522 (1995-10-01), None
patent: 688772 (1995-12-01), None
patent: 976749 (2000-02-01), None
patent: 1031569 (2000-08-01), None
patent: 48-472 (1973-09-01), None
patent: 64-90184 (1989-04-01), None
patent: 6-70456 (1994-03-01), None
patent: 6-73056 (1994-03-01), None
patent: 6-263754 (1994-09-01), None
patent: 10-130241 (1998-05-01), None
patent: WO 92/09579 (1992-11-01), None
patent: WO 92/22550 (1992-12-01), None
patent: WO 94/07873 (1994-04-01), None
patent: WO 94/15933 (1994-07-01), None
patent: WO 96/19472 (1996-06-01), None
patent: WO 97/11068 (1997-03-01), None
patent: WO 97/29102 (1997-08-01), None
patent: WO 99/14214 (1999-03-01), None
patent: WO 00/31062 (2000-02-01), None
patent: WO 00/49192 (2000-08-01), None
patent: WO 00/71541 (2000-11-01), None
patent: WO 01/18005 (2001-03-01), None
patent: WO 01/36408 (2001-05-01), None
patent: WO 01/85728 (2001-11-01), None
patent: WO 02/09758 (2002-02-01), None
patent: WO 02/48138 (2002-06-01), None
patent: WO 02/085886 (2002-10-01), None
patent: WO 03/011450 (2003-02-01), None
patent: WO 03/014108 (2003-02-01), None
patent: WO 03/028665 (2003-04-01), None
patent: WO 03/050107 (2003-06-01), None
Mitten et al., Antimicrobial agents and chemotherapy, (Sep. 2001) vol. 45, No. 9, pp. 2585-2593.
Albrecht, R. “Development of Antibacterial Agents of the Nalidixic Acid Type”, Antibacterial Agents, vol. 21 (1977) pp. 9-104.
Cornett, J. B., et al. “Chapter 14, Quinolone Antibacterial Agents”, Annual Reports in Medicinal Chemistry, vol. 21 (1986) pp. 139-148.
Domagala, J. M., et al. “1-Substituted 7-[3-[(Ethylamino)methyl]-1-pyrrolidinyl]- 6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative Structure-Activity Relationships at N1for the Quinolone Antibacterials”, J. Medicinal Chemistry (1988) vol. 31, pp. 991-1001.
Fernandes, P., et al. “Section III—Chemotherpeutic Agents, Chapter 12, quinolones”, Annual Rpeorts in Medicinal Chemistry, vol. 22 (1987) pp. 117-126.
Klopman, G., et al. “Computer Automated Structure Evaluation of Quinolone Antiabacterial Agents”, Antimicrobial Agents and Chemotherapy, (1987), vol. 31, No. 11, pp. 1831-1840.
Koga, H., et al. “Structure-Activity Relationships of Antibacterial 6,7- and 7,8- Disubstituted 1-Alkyl-1,4-dihydro-4-oxoquinolone-3-carboxylic Acids”, J. Medical Chemistry (1980) vol. 23, pp. 1358-1363.
Kuramoto, Y., et al. “A Novel Antibacterial 8-Chloroquinolone with a Distorted Orientation of the N1-(5-Amino-2,4-difluorophenyl) Group”, J. Medical Chemistry (2003) vol. 46, pp. 1905-1917.
Ledoussal, B., et al. “Potent Non-6-Fluoro-Substiturted Quinolone Antibacterials: Synthesis and Biological Activity”, J. Medical Chemistry (1992) vol. 35, pp. 198-200.
Rosen, T., et al. “Design, Synthesis, and Properties of (4S)-7-(4-Amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic Acids”, J. Medicinal Chemistry (1988) vol. 31,pp. 1958-1611.
Ruiz, J. “Mechanisms of Resistance to Quinolones; Target Alterations, Decreased Accumulation and DNA Gyrase Protection”, Journal of Antimicrobial Chemotherapy (2003) vol. 51, pp. 1109-1117.
Sanders, W., et al. “Inducible β-Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins”, Review of Infectious Diseases, vol. 10, No. 4 (1988) pp. 830-838.
Wentland, M., et al. “Chapter 15. Quinolone Antibacterial Agents”, Annual Reports in Medicinal Chemistry.
Wolfson, J., et al. “The Fluoroquinolones; Structures, Mechanisms of Action and Resistance, and Specra of Activity in Vitro”, Antimicrobial Agents and Chemotherapy(1985) vol. 28, No. 4 pp. 581-586.
Ziegler, C., et al. “Synthesis of Some Novel 7-Substituted Quinolonecarboxylic AcidsviaNitroso and Nitrone Cycloadditions”, J. Heterocyclic Chemistry, vol. 25 (1988) pp. 719-723.
Lin Shu-Chen
Macielag Mark J.
Weidner-Wells Michele A.
Dodd Thomas
Janssen Pharmaceutica NV.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
C-7 isoxazolinyl quinolone / naphthyridine derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C-7 isoxazolinyl quinolone / naphthyridine derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-7 isoxazolinyl quinolone / naphthyridine derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740859